NCT00779636View on ClinicalTrials.gov

Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)

PHASE4CompletedINTERVENTIONAL
Enrollment

506

Participants

Timeline

Start Date

July 1, 2003

Primary Completion Date

November 1, 2004

Study Completion Date

November 1, 2004

Conditions
Allergic Airway Disease
Interventions
DRUG

Desloratadine

Desloratadine 10 mg daily x 28 days

DRUG

Placebo

Placebo daily x 28 days

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00779636 - Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284) | Biotech Hunter | Biotech Hunter